Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Guelph

$30,000.00

A hydrogel-based bacteria concentrator for rapid highly sensitive detection of Legionella in water

EF 2024-25

Résumé
The proposed research project involves a collaboration between Dr. Huiyan Li's laboratory at the University of Guelph (Guelph, Ontario) and Cytodiagnostics Inc. (Burlington, Ontario). We aim to develop a prototype of a hydrogel-based bacteria concentrator that can be integrated with Cytodiagnostics' lateral flow assay for the rapid detection of Legionella bacteria in water samples. Legionella is a pathogenic rod-shaped bacterium found in various water sources, both man-made and natural, including water towers, hot tubs, swimming pools, drinking water, lakes, rivers, and ponds. It is responsible for two lung diseases: Legionnaires' disease, a severe pneumonia with an overall death rate of 5-10% globally contracted by inhaling mist containing the bacteria, and Pontiac fever, a milder respiratory disease. In Ontario alone, Legionella infection resulted in 269 hospitalizations and 21 deaths in 2022. However, to date, there is a lack of rapid and highly sensitive tests for Legionella detection in water. Current testing practices require sending water samples to a centralized laboratory, with results taking up to 14 business days to receive, leading to delays in water treatment. This collaboration aims to combine Cytodiagnostics' expertise in rapid bacteria testing with Dr. Li's strength in hydrogel-based bioassays to create a highly sensitive, rapid Legionella water test, enabling timely water treatment, and improving public health and safety across Canada. This project has significant implications for Canada's biotechnology sector, supporting the nation's goal to double its health and biosciences sector and become a top-3 global hub by 2025. The technology will be commercialized by Cytodiagnostics, a Canadian biotech company, contributing to Canada's economic growth and job creation. Furthermore, the training to be provided through this research will contribute to the long-term sustainability and growth of the Canadian biotechnology industry.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
598473-2024
Name nom
Li, Huiyan H
Department département
Engineering, School of
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
A hydrogel-based bacteria concentrator for rapid highly sensitive detection of Legionella in water
Keywords
assay sensitivity; bacteria concentration; hydrogel; lateral flow assay; legionella detection; turnaround time; water samples
Application summary
The proposed research project involves a collaboration between Dr. Huiyan Li's laboratory at the University of Guelph (Guelph, Ontario) and Cytodiagnostics Inc. (Burlington, Ontario). We aim to develop a prototype of a hydrogel-based bacteria concentrator that can be integrated with Cytodiagnostics' lateral flow assay for the rapid detection of Legionella bacteria in water samples. Legionella is a pathogenic rod-shaped bacterium found in various water sources, both man-made and natural, including water towers, hot tubs, swimming pools, drinking water, lakes, rivers, and ponds. It is responsible for two lung diseases: Legionnaires' disease, a severe pneumonia with an overall death rate of 5-10% globally contracted by inhaling mist containing the bacteria, and Pontiac fever, a milder respiratory disease. In Ontario alone, Legionella infection resulted in 269 hospitalizations and 21 deaths in 2022. However, to date, there is a lack of rapid and highly sensitive tests for Legionella detection in water. Current testing practices require sending water samples to a centralized laboratory, with results taking up to 14 business days to receive, leading to delays in water treatment. This collaboration aims to combine Cytodiagnostics' expertise in rapid bacteria testing with Dr. Li's strength in hydrogel-based bioassays to create a highly sensitive, rapid Legionella water test, enabling timely water treatment, and improving public health and safety across Canada. This project has significant implications for Canada's biotechnology sector, supporting the nation's goal to double its health and biosciences sector and become a top-3 global hub by 2025. The technology will be commercialized by Cytodiagnostics, a Canadian biotech company, contributing to Canada's economic growth and job creation. Furthermore, the training to be provided through this research will contribute to the long-term sustainability and growth of the Canadian biotechnology industry.